Correction: Combined Inhibition of Bcl-2 and Mcl-1 Overcomes Bax Deficiency-Mediated Resistance of TP53-Mutant Acute Myeloid Leukemia to Individual BH3 Mimetics

Authors

Bing Z Carter
Po Yee Mak
Wenjing Tao
Edward Ayoub
Lauren B Ostermann
Xuelin Huang
Sanam Loghavi
Steffen Boettcher
Yuki Nishida
Vivian Ruvolo
Paul E Hughes
Phuong K Morrow
Torsten Haferlach
Steven Kornblau
Muharrem Muftuoglu
Michael Andreeff

Language

English

Publication Date

5-17-2023

Journal

Blood Cancer Journal

DOI

10.1038/s41408-023-00857-z

PMID

37193700

PMCID

PMC10188521

PubMedCentral® Posted Date

5-17-2023

PubMedCentral® Full Text Version

Post-print

Comments

This corrects the article "Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics", 57.

Published Open-Access

yes

Recommended Citation

Carter, Bing Z; Mak, Po Yee; Tao, Wenjing; et al., "Correction: Combined Inhibition of Bcl-2 and Mcl-1 Overcomes Bax Deficiency-Mediated Resistance of TP53-Mutant Acute Myeloid Leukemia to Individual BH3 Mimetics" (2023). Faculty, Staff and Student Publications. 5281.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5281